Published in Vopr Virusol on October 04, 2010
Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A (2001) 9.40
Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun (1992) 1.27
Construction of a Streptococcus pyogenes recA mutant via insertional inactivation, and cloning and sequencing of the complete recA gene. Gene (1995) 0.89
Structural and functional similarity of C5a-ase enzymes from group A and B streptococci. Adv Exp Med Biol (1997) 0.83
The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Benef Microbes (2010) 0.81
[The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumors]. Vopr Onkol (2000) 0.80
Studies of natural population variability of parainfluenza viruses during their epidemic circulation. Acta Virol (1991) 0.80
Treatment of Helicobacter pylori positive duodenal ulcers. Lancet (1990) 0.80
[Gastroesophageal reflux disease and respiratory apparatus pathology: the evidence of interrelation and unsolved problems]. Vestn Ross Akad Med Nauk (2005) 0.78
Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity. Folia Microbiol (Praha) (2005) 0.78
The Streptococcus pyogenes genome sequencing project. A progress report. Adv Exp Med Biol (1997) 0.78
[Influence of probiotic enterococci on the growth of Streptococcus agalactiae]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.78
Analysis of pathogenic group B streptococci by pulsed field gel electrophoresis. Adv Exp Med Biol (1997) 0.78
[Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)]. Eksp Klin Gastroenterol (2013) 0.78
[Experimental evaluation of recombinant polypeptides as Streptococcus Group B vaccine]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.77
[Quantitative characterization of antagonistic activity of lactobacilli]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.77
Gastric cancer screening in selected population of Moscow region: retrospective evaluation. Eur Radiol (1999) 0.77
[PROBIOTICS, NUTRITIONAL STATUS AND RESISTANCE TO RESPIRATORY INFECTIONS IN INFANTS]. Eksp Klin Gastroenterol (2015) 0.77
[Protective properties of certain external proteins of group B streptococci]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.77
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]. Eksp Klin Gastroenterol (2003) 0.77
[Helicobacter pylori, endocrine cells of the gastric mucosa, and their function in duodenal ulcer]. Arkh Patol (1996) 0.77
[The role of genetic features of Helicobacter pylori in pathogenesis of digestive system diseases: from theory to practice]. Eksp Klin Gastroenterol (2009) 0.76
[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76
[Efficacy of using inulin fortified fermented milk products in patients with functional constipation]. Vopr Pitan (2009) 0.75
[Varying sensitivity to acyclovir of different years' clinical isolates of herpes simplex virus]. Vestn Ross Akad Med Nauk (1995) 0.75
[Experience with transendoscopic ultrasonic therapy of stomach ulcer]. Klin Med (Mosk) (1990) 0.75
[Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Klin Med (Mosk) (1991) 0.75
[Class I histocompatibility antigens as markers of human susceptibility to influenza A viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Pharmacologic effect of anthropogenic air pollutants on children and prognosis for correction of these disorders]. Vestn Ross Akad Med Nauk (1994) 0.75
[Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine]. Vopr Virusol (2013) 0.75
[Current possibilities of X-ray diagnosis of small intestine diseases using the agent Entero-view]. Vestn Rentgenol Radiol (2001) 0.75
[Use of sucralfate in the treatment of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Autochthonous probiotics in prevention of infectious and inflammatory diseases of a human in the altered habitats]. Vestn Ross Akad Med Nauk (2013) 0.75
[Phases of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Gastroesophageal reflux disease and Helicobacter pylori]. Klin Med (Mosk) (2000) 0.75
[Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump]. Ter Arkh (2005) 0.75
[Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study]. Eksp Klin Gastroenterol (2003) 0.75
[Clinical characterization of patients with HIV infections]. Sov Med (1989) 0.75
[Famotidine--a new histamine H2 receptor blockader]. Klin Med (Mosk) (1991) 0.75
[Clinical and x-ray features of lung lesions in influenza uncomplicated and complicated by pneumonia]. Vestn Ross Akad Med Nauk (1995) 0.75
[A complicated case of diagnosis of ileo-cecal tuberculosis]. Klin Med (Mosk) (2001) 0.75
[Losek therapy of duodenal ulcer in contamination with different strains of Helicobacter pylori]. Klin Med (Mosk) (1999) 0.75
[Problem of the choice of the probiotic dose in the physician practice]. Eksp Klin Gastroenterol (2014) 0.75
[Helicobacter pylori and its role in pathology]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer]. Sov Med (1991) 0.75
[Local factors in the pathogenesis of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Ter Arkh (1988) 0.75
[Pharmacoeconomics in helicobacter pylori infection (lecture)]. Ter Arkh (2000) 0.75
[The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer]. Klin Med (Mosk) (1993) 0.75
[Current views on the etiology and pathogenesis of peptic ulcer]. Vestn Akad Med Nauk SSSR (1990) 0.75
[Campylobacter pyloridis in chronic gastritis and peptic ulcer]. Sov Med (1988) 0.75
[Current concepts of chronic gastritis (a review of the literature)]. Vrach Delo (1988) 0.75
[Selection of the surgery method for patients with high "stomach ulcers"]. Eksp Klin Gastroenterol (2005) 0.75
[Experience with the treatment of duodenal ulcer associated with Campylobacter pylori infection by combined use of anti-secretory and antibacterial drugs]. Klin Med (Mosk) (1989) 0.75
[Mortality and lethality of influenza and acute respiratory diseases]. Vestn Ross Akad Med Nauk (1994) 0.75
[Serological methods of diagnosis of Helicobacter pylori infections: recommendations and perspective of use]. Klin Lab Diagn (2000) 0.75
[Chronic pancreatitis: current theories on its etiology, pathogenesis, clinical course and drug treatment (review of foreign literature)]. Klin Med (Mosk) (1988) 0.75
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
[Pathophysiologic bases of the pharmacotherapy of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[The diagnosis of stomach cancer: the status of the problem, the outlook for improvement and the clinico-morphological aspects]. Ter Arkh (1997) 0.75
[Use of cyclophosphane pulse-therapy in the treatment of severe nonspecific ulcerative colitis]. Klin Med (Mosk) (1994) 0.75
[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?]. Klin Med (Mosk) (2005) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[New aspects in the etiology and pathogenesis of chronic gastritis and peptic ulcer]. Ter Arkh (1988) 0.75
[Value of probiotic in reducing frequency of infectious complications in premature infants]. Antibiot Khimioter (2014) 0.75
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. Ter Arkh (2003) 0.75
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes]. Eksp Klin Gastroenterol (2004) 0.75
[Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors]. Eksp Klin Gastroenterol (2003) 0.75
[Functional activity of neutrophilic granulocytes in patients with relapsing herpes]. Biull Eksp Biol Med (1995) 0.75
[Epidemiologic aspects of human herpes virus infection type VI]. Vestn Ross Akad Med Nauk (1994) 0.75
[A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis]. Lab Delo (1989) 0.75
[GERD epidemiology: East and West]. Eksp Klin Gastroenterol (2004) 0.75
[The pathogenetic bases of alimentary obesity]. Ter Arkh (1989) 0.75
[Liver damage caused by HIV infection]. Klin Med (Mosk) (1989) 0.75
[A non-invasive method of evaluation of Helicobacter pylori urease activity: its perfection and introduction to clinical practice]. Vestn Ross Akad Med Nauk (2006) 0.75
[A case of death from AIDS in the USSR]. Ter Arkh (1989) 0.75
[Etiologic and pathologic approaches to pharmacotherapy of peptic ulcer]. Ter Arkh (1991) 0.75
[Treatment of cholelithiasis]. Sov Med (1988) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[The role of gastroesophageal reflux in malignization of post-burn and peptic esophageal strictures]. Vestn Ross Akad Med Nauk (2005) 0.75
[Use in immunohistochemical studies of a method of restoration of antigenic specificity as affected by microwaves in tissue fixed with formalin and embedded in paraffin]. Arkh Patol (1999) 0.75
[Optimal diagnosis and therapy of gastroesophageal reflux disease]. Ter Arkh (2004) 0.75
[Hepatic encephalopathy: its etiology, pathogenesis, clinical diagnostic criteria and treatment principles]. Ter Arkh (1990) 0.75
[Evaluation of contamination of the gastric mucosa with Helicobacter pylori and activity of chronic gastritis]. Arkh Patol (1995) 0.75
[The epidemiological aspects of infection caused by the lymphotropic herpesvirus 6]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[Causes of postoperative recurrence and therapy of peptic ulcer]. Klin Med (Mosk) (1990) 0.75
[Project. Therapy of acid-dependent diseases. First Moscow Agreement, February 5, 2003]. Eksp Klin Gastroenterol (2003) 0.75
[Effectiveness of lamivudine in the treatment of chronic HBeAg-negative viral hepatitis B: results of continuous therapy for 18 months]. Klin Med (Mosk) (2003) 0.75
[Chronic gastritis: current theories on its pathogenesis, clinical course and treatment]. Ter Arkh (1989) 0.75
[Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3]. Antibiot Khimioter (2013) 0.75
[Characteristics of the endoscopic diagnosis of peptic ulcer and chronic gastritis associated with Campylobacter pylori]. Ter Arkh (1989) 0.75
[Diagnosis of measles in the outpatient polyclinic service]. Ter Arkh (1985) 0.75
[The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori]. Ter Arkh (1992) 0.75
[Concept of the mechanism of the therapeutic effect of flu chemotherapy]. Dokl Akad Nauk (1992) 0.75
[Isolation and properties of superoxide dismutase from human blood plasma]. Biokhimiia (1992) 0.75
[Photochemotherapy in the treatment of acute pneumonias]. Vestn Ross Akad Med Nauk (1994) 0.75